Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDA accelerated approval benefits glioblastoma.

× No keyword cloud information.

11 in total

Review 1. Reappraising antiangiogenic therapy for breast cancer.

Authors: Robert S Kerbel
Journal: Breast Date: 2011-10 Impact factor: 4.380

2. Small-animal PET demonstrates brain metabolic change after using bevacizumab in a rat model of cerebral ischemic injury.

Authors: Ying Dong; Fahuan Song; Jianjuan Ma; Xuexin He; Said Amer; Weizhong Gu; Mei Tian
Journal: Neurosci Bull Date: 2014-09-28 Impact factor: 5.203

Review 3. Applications of high-resolution magic angle spinning MRS in biomedical studies I-cell line and animal models.

Authors: Eva Kaebisch; Taylor L Fuss; Lindsey A Vandergrift; Karin Toews; Piet Habbel; Leo L Cheng
Journal: NMR Biomed Date: 2017-03-16 Impact factor: 4.044

Review 4. From bench to FDA to bedside: US regulatory trends for new stem cell therapies.

Authors: Paul S Knoepfler
Journal: Adv Drug Deliv Rev Date: 2014-12-07 Impact factor: 15.470

Review 5. Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy?

Authors: Alessia Bottos; Alberto Bardelli
Journal: Cell Mol Life Sci Date: 2013-05-18 Impact factor: 9.261

Review 6. Cellular-based immunotherapies for patients with glioblastoma multiforme.

Authors: Xun Xu; Florian Stockhammer; Michael Schmitt
Journal: Clin Dev Immunol Date: 2012-02-28

7. Metabolic impact of anti-angiogenic agents on U87 glioma cells.

Authors: Tanja Mesti; Philippe Savarin; Mohamed N Triba; Laurence Le Moyec; Janja Ocvirk; Claire Banissi; Antoine F Carpentier
Journal: PLoS One Date: 2014-06-12 Impact factor: 3.240

8. Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis.

Authors: Celina Bihan; Sylvain Foscolo; Mathieu Boone; Marie Blonski; Alexandre Coutte; Amélie Darlix; Patrick Beauchesne; Michel Lefranc; Veronique Lorgis; Luc Taillandier; Bruno Chauffert
Journal: Case Rep Oncol Date: 2012-09-29

9. Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?

Authors: Kerrie L McDonald; Grace Aw; Paul Kleihues
Journal: Front Neurol Date: 2013-01-18 Impact factor: 4.003

Review 10. New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.

Authors: Roberto Würth; Federica Barbieri; Tullio Florio
Journal: Biomed Res Int Date: 2014-01-02 Impact factor: 3.411